Comparing Tempus AI (NASDAQ:TEM) and Tivic Health Systems (NASDAQ:TIVC)

Tempus AI (NASDAQ:TEMGet Free Report) and Tivic Health Systems (NASDAQ:TIVCGet Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership.

Profitability

This table compares Tempus AI and Tivic Health Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Tempus AI -20.98% -122.86% -18.09%
Tivic Health Systems -148.49% -22.69% -18.94%

Analyst Recommendations

This is a breakdown of recent recommendations for Tempus AI and Tivic Health Systems, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tempus AI 1 8 7 0 2.38
Tivic Health Systems 1 0 0 0 1.00

Tempus AI currently has a consensus target price of $79.38, indicating a potential downside of 13.32%. Given Tempus AI’s stronger consensus rating and higher possible upside, equities analysts plainly believe Tempus AI is more favorable than Tivic Health Systems.

Institutional & Insider Ownership

24.2% of Tempus AI shares are held by institutional investors. Comparatively, 4.3% of Tivic Health Systems shares are held by institutional investors. 26.3% of Tempus AI shares are held by insiders. Comparatively, 0.5% of Tivic Health Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Tempus AI and Tivic Health Systems”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tempus AI $693.40 million 22.95 -$705.81 million ($1.19) -76.96
Tivic Health Systems $780,000.00 3.88 -$9.31 million ($8.62) -0.32

Tivic Health Systems has lower revenue, but higher earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Tivic Health Systems, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Tempus AI has a beta of 4.87, indicating that its stock price is 387% more volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 1.96, indicating that its stock price is 96% more volatile than the S&P 500.

Summary

Tempus AI beats Tivic Health Systems on 11 of the 14 factors compared between the two stocks.

About Tempus AI

(Get Free Report)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

About Tivic Health Systems

(Get Free Report)

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.